This is a non-core endpoint: only basic statistics are computed.
Benign neoplasm: Connective and other soft tissue, unspecified
CD2_BENIGN_CONNSOFT_NOS_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D21
- Name in latin
- Neoplasma benignum textus connectivi sive alterius textus mollis non specificatum
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Connective and other soft tissue, unspecified
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Connective and other soft tissue, unspecified
- Other benign neoplasms of connective and other soft tissue
- Other benign neoplasms of connective and other soft tissue
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 423 | 260 | 163 |
| Unadjusted period prevalence (%) | 0.08 | 0.09 | 0.07 |
| Median age at first event (years) | 49.77 | 49.04 | 50.93 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 381
- Matched controls
- 3810
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D21.9
ICD-10 Finland
Benign neoplasm: Connective and other soft tissue, unspecified
9296.2
323.0
304
*
21509
ICD-8 Finland
Other benign neoplasm of muscular and connective tissue, Unspecified
+∞
55.6
52
*
130
Kela drug reimbursment
Malignant tumour
+∞
22.1
21
*
NDR20
NOMESCO Finland
Incomplete excision of soft tissue tumour of wrist or hand
15.9
21.6
35
24
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
8.4
17.6
39
51
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
6.7
17.3
45
75
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
16.8
16
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
15.7
15
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
15.7
15
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
15.7
15
*
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
11.1
15.5
29
28
D48.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue
11.1
15.0
28
27
D21.1
ICD-10 Finland
Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder
23.3
14.4
20
9
115
Kela drug reimbursment
Breast cancer
+∞
13.6
13
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
13.6
13
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
+∞
13.6
13
*
2159X
ICD-9 Finland
Other benign neoplasm of connective and other soft tissue, Site unspecified
+∞
13.6
13
*
R22.3
ICD-10 Finland
Localized swelling, mass and lump, upper limb
11.0
12.9
24
23
D21.2
ICD-10 Finland
Benign neoplasm: Connective and other soft tissue of lower limb, including hip
33.3
12.7
16
5
A03FA01
ATC
metoclopramide; systemic, rectal
3.2
12.0
67
237
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
13.1
11.8
20
16
WF002
NOMESCO Finland
Radical radiotherapy
67.0
11.7
13
*
NDM99
NOMESCO Finland
Other operation on fascia, ganglion, synovial sheath or bursa of wrist or hand
44.7
11.0
13
*
A04AA02
ATC
granisetron; systemic, transdermal
112.9
10.5
11
*
NDR30
NOMESCO Finland
Complete excision of soft tissue tumour of wrist or hand
112.9
10.5
11
*
116
Kela drug reimbursment
Prostate cancer
+∞
9.4
9
*
L01BC06
ATC
capecitabine; oral
+∞
9.4
9
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
9.4
9
*
XX3DW
NOMESCO Finland
Time consuming IT work
4.4
9.2
33
81
WZC30
NOMESCO Finland
Teaching
3.2
9.0
50
174
9736
FHL
Subcutaneous tumor removal in operating room or anesthesia
9.8
8.9
17
18
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
51.2
8.7
10
*
NHR20
NOMESCO Finland
Incomplete excision of soft tissue tumour of ankle or foot
51.2
8.7
10
*
WX402
NOMESCO Finland
General anaesthesia
2.6
8.4
62
262
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
8.4
8
*
QBE99
NOMESCO Finland
Other excision or repair of lesion of skin of trunk
9.2
8.1
16
18
N02BE01
ATC
paracetamol; systemic, rectal
2.2
8.1
323
2722
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
7.7
7.8
17
23
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
45.9
7.7
9
*
JN4BD
NOMESCO Finland
Extensive body CT
3.9
7.7
30
81
JN4AD
NOMESCO Finland
Body CT examination
5.6
7.6
21
39
D17.1
ICD-10 Finland
Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk
5.5
7.5
21
40
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
7.3
7
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
7.3
7
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
7.3
7
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
7.3
7
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
7.3
7
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
7.3
7
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
7.3
7
*
SPAT1153
SPAT
Removal of sutures
1.9
7.3
121
735
H02AB02
ATC
dexamethasone; systemic
9.0
7.1
14
16
HAB40
NOMESCO Finland
Wedge excision of mammary gland
23.0
6.7
9
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.9
6.5
106
636
S18
ICPC
Laceration/cut
1.8
6.3
153
1051
21505
ICD-8 Finland
Other benign neoplasm of muscular and connective tissue, Loco multiplici
+∞
6.3
6
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
6.3
6
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
6.3
6
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
6.3
6
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
6.3
6
*
D17.0
ICD-10 Finland
Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck
7.9
6.2
13
17
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
5.1
6.1
18
37
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
212
1556
1.73
7.02
6.2
3.7
11.8
11.1
umol/l
0.35
202
1462
191
1367
1.72
6.89
6.3
4.6
1.2
1.2
mmol/l
0.07
177
1209
193
1397
1.70
6.60
3.8
3.5
—
—
—
0
0
75
419
1.96
6.02
17.2
20.7
1.4
1.3
inr
—
7
62
48
228
2.25
5.88
2.2
1.7
66.2
68.2
g/l
0.88
43
208
229
1782
1.62
5.59
9.0
6.6
3.9
4.1
e9/l
0.78
203
1557
298
2477
1.69
5.59
7.8
5.2
73.6
74.4
u/l
0.20
284
2279
17
48
3.65
5.38
1.3
1.3
—
—
—
0
0
109
728
1.67
4.77
1.7
1.7
0.9
0.9
mg/l
0.00
94
552
232
1861
1.55
4.62
4.6
3.9
6.9
6.7
mmol/l
0.41
219
1715
195
1509
1.54
4.56
6.9
5.1
1.2
1.2
mmol/l
0.32
156
1291
138
1004
1.56
4.18
3.7
2.0
2.4
2.4
mmol/l
0.35
125
841
119
840
1.58
4.10
3.0
2.2
331.1
6541.8
umol/l
3.18
113
736
165
1264
1.50
3.88
4.8
3.5
35.7
36.0
g/l
0.37
153
1170
374
3422
1.80
3.73
16.0
11.1
19.7
21.6
mg/l
0.63
306
2593
296
2572
1.50
3.58
5.0
4.1
11.4
11.2
mm/h
0.12
281
2369
60
368
1.73
3.55
3.2
2.3
23.0
24.4
%
0.29
53
316
357
3249
1.63
3.34
15.3
9.9
82.4
81.5
ml/min/173m2
0.35
307
2616
93
652
1.55
3.24
1.3
1.3
22.9
33.6
iu/ml
1.06
34
216
125
936
1.48
3.19
2.9
2.9
1581.6
1197.8
ng/l
0.34
116
784
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
6
8
7.59
3.06
2.8
2.4
116.7
104.2
%
—
6
8
116
866
1.47
2.98
3.6
2.7
0.4
0.4
e6/l
0.07
93
645
44
261
1.77
2.94
3.4
1.9
63.2
69.2
ml/min/173m2
0.33
17
102
93
668
1.50
2.88
2.1
1.9
—
—
—
0
0
318
2858
1.45
2.79
19.6
13.3
13.6
13.6
%
0.50
311
2795
391
3680
1.83
2.78
18.8
12.6
76.6
75.8
umol/l
0.19
391
3680
12
42
2.91
2.77
1.0
1.3
—
—
—
0
0
51
324
1.65
2.68
6.8
6.7
-0.2
1.5
mmol/l
1.16
42
255
11
38
2.95
2.60
2.5
1.7
87.0
90.4
%
0.47
11
38
117
896
1.42
2.59
4.4
3.7
0.0
0.0
estimate
0.17
51
292
51
327
1.64
2.59
2.4
2.2
8.0
7.2
umol/l
0.09
44
283
21
101
2.14
2.57
1.3
1.5
2.8
3.0
g/l
0.83
15
79
298
2669
1.39
2.49
4.2
3.8
14.9
14.7
pmol/l
0.59
279
2435
195
1635
1.36
2.48
3.9
3.5
0.0
0.0
estimate
0.49
51
297
195
1641
1.35
2.40
4.9
4.7
0.0
0.0
estimate
0.00
55
295
14
58
2.46
2.39
3.0
2.1
15.0
16.0
%
—
6
27
21
106
2.03
2.29
1.4
1.5
—
—
—
0
0
21
106
2.03
2.29
1.4
1.5
3.3
3.9
g/l
1.32
15
78
21
106
2.03
2.29
1.4
1.5
7.0
7.6
g/l
0.90
16
80
129
1024
1.37
2.29
2.4
2.1
191.6
239.6
u/l
0.27
119
960
14
61
2.34
2.17
1.2
1.7
—
—
—
0
0
195
1664
1.32
2.10
3.9
3.5
0.0
0.0
estimate
0.50
55
291
15
69
2.22
2.07
2.0
1.3
—
—
—
0
0
15
69
2.22
2.07
2.4
1.8
124.8
128.7
g/l
—
9
51
44
292
1.57
1.97
3.2
2.9
—
—
—
0
0
12
51
2.39
1.96
1.3
1.1
3.0
1.8
u/ml
—
5
19
12
51
2.39
1.96
1.4
1.3
—
—
—
0
0
152
1266
1.31
1.91
4.2
3.5
23.1
39.1
ng/l
1.86
98
849
344
3207
1.39
1.88
5.2
4.6
1.9
2.3
mu/l
0.54
326
2931
246
2194
1.29
1.81
2.8
3.0
—
—
—
0
0
10
41
2.47
1.76
1.1
1.4
—
—
—
0
0
6
18
3.37
1.75
1.5
1.2
28.0
30.7
umol/l
—
6
18
153
1289
1.29
1.74
4.0
3.6
—
—
—
0
0
33
211
1.61
1.74
2.0
2.2
13.5
15.2
nmol/l
0.90
28
187
362
3417
1.41
1.72
4.7
4.4
5.9
5.9
mmol/l
0.23
334
3125
5
13
3.88
1.72
1.2
1.5
—
—
—
0
0
5
13
3.88
1.72
1.2
1.6
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
15
75
2.04
1.71
3.1
2.5
0.3
0.3
u/ml
—
8
41
6
19
3.19
1.66
1.3
1.2
—
—
—
0
0
7
25
2.83
1.65
1.0
1.0
—
—
—
0
0
18
98
1.87
1.64
1.1
1.1
—
9.4
—
0
13
29
183
1.63
1.62
1.7
1.5
—
—
—
0
0
65
489
1.39
1.58
3.6
2.6
1.5
2.9
e6/l
1.69
38
252
11
51
2.19
1.52
1.1
1.1
—
—
—
0
0
96
775
1.31
1.48
1.4
1.3
2.0
2.2
u/ml
0.05
24
222
16
87
1.87
1.48
1.5
1.3
—
—
—
0
0
11
52
2.15
1.45
1.1
1.3
0.6
0.6
nmol/l
0.03
11
46
81
641
1.33
1.44
1.3
1.2
12.6
12.4
u/ml
0.01
32
248
5
16
3.15
1.44
1.2
1.4
—
—
—
0
0
5
16
3.15
1.44
1.8
3.3
605.2
1386.0
u/ml
—
5
16
10
46
2.20
1.41
1.4
1.5
—
—
—
0
0
7
29
2.44
1.39
4.3
3.6
—
—
—
0
0
9
41
2.22
1.37
1.0
1.2
117.4
394.8
pmol/l
—
9
31
9
41
2.22
1.37
1.1
1.3
—
—
—
0
0
385
3702
1.45
1.36
11.2
8.4
25.2
25.7
u/l
0.26
376
3553
43
315
1.41
1.25
1.8
1.7
—
—
—
0
0
9
45
2.02
1.24
1.4
1.0
—
—
—
0
0
10
49
2.07
1.23
1.1
1.1
—
—
—
0
0
371
3558
1.35
1.21
4.9
4.9
2.7
2.8
mmol/l
0.96
350
3300
15
86
1.77
1.20
1.2
1.1
—
—
—
0
0
12
64
1.90
1.19
1.8
1.7
—
—
—
0
0
13
72
1.83
1.16
5.1
2.4
8.6
8.2
kpa
0.61
13
63
8
39
2.07
1.16
1.3
1.0
—
—
—
0
0
11
58
1.92
1.13
1.7
1.5
—
—
—
0
0
70
564
1.29
1.11
2.9
1.9
2.5
2.4
mmol/l
1.14
63
481
76
619
1.28
1.11
3.5
3.7
472.4
257.5
ng/l
0.38
57
468
14
81
1.75
1.10
1.4
1.4
—
—
—
0
0
15
89
1.71
1.09
2.1
2.3
39.1
96.4
ug/min
—
10
53
7
33
2.14
1.06
1.0
1.2
—
—
—
0
0
65
525
1.28
1.02
3.1
2.6
0.8
0.8
ug/l
0.09
46
336
10
53
1.91
1.02
1.4
1.6
—
—
—
0
0
363
3491
1.28
1.00
4.4
4.4
4.6
4.7
mmol/l
0.96
341
3252
5
23
2.19
0.98
1.2
1.2
5.7
6.8
mmol/l
—
5
23
7
37
1.91
0.94
1.1
1.4
—
—
—
0
0
337
3223
1.22
0.91
5.9
5.6
39.6
39.6
mmol/mol
0.06
314
3007
41
316
1.33
0.91
1.9
1.8
—
—
—
0
0
57
462
1.27
0.88
2.0
1.7
—
—
—
0
0
8
43
1.88
0.87
1.4
1.5
—
—
—
0
0
11
64
1.74
0.87
3.4
4.2
57.5
57.6
%
0.01
11
64
30
223
1.37
0.84
2.9
2.4
4.6
4.6
kpa
0.05
30
213
10
57
1.77
0.84
1.4
1.6
—
—
—
0
0
8
46
1.75
0.83
1.1
1.1
—
—
—
0
0
118
1040
1.19
0.83
2.2
2.1
53.1
58.0
u/l
1.17
110
954
156
1408
1.17
0.82
2.5
2.3
79.4
77.1
nmol/l
0.44
144
1256
162
1470
1.17
0.79
3.4
2.6
107.9
102.9
ug/l
0.17
151
1357
82
702
1.21
0.79
1.9
1.7
442.4
19416234.6
pmol/l
0.76
63
582
17
115
1.50
0.78
1.6
1.2
26.4
24.8
iu/l
0.08
17
98
6
34
1.78
0.76
1.5
1.6
—
—
—
0
0
106
932
1.18
0.76
5.1
3.8
2.0
2.0
ug/l
0.03
95
828
90
781
1.19
0.75
1.6
1.5
19.6
21.4
nmol/l
0.52
76
670
8
133
0.59
0.74
1.5
1.8
—
—
—
0
0
16
108
1.50
0.74
3.1
2.1
451.7
702.3
ug/l
0.23
16
99
7
38
1.86
0.74
1.4
1.4
—
—
—
0
0
5
25
2.01
0.73
1.6
1.0
—
—
—
0
0
25
187
1.36
0.70
1.3
1.5
—
—
—
0
0
5
27
1.86
0.68
1.2
1.1
—
—
—
0
0
358
3471
1.20
0.68
4.4
4.4
1.5
1.5
mmol/l
0.13
336
3223
90
789
1.18
0.67
2.4
2.1
3.3
2.9
mg/l
0.31
75
667
23
304
0.74
0.67
1.3
2.5
15.0
6.9
ug/l
0.65
17
264
5
28
1.79
0.66
1.6
1.6
—
—
—
0
0
5
29
1.73
0.64
1.4
1.5
—
—
—
0
0
118
1062
1.15
0.64
4.3
4.0
7.9
8.5
mg/mmol
0.09
83
646
85
746
1.17
0.63
4.5
3.6
21.4
24.2
%
0.73
40
330
104
930
1.16
0.61
1.5
1.6
1.4
1.4
mmol/l
0.07
90
790
34
274
1.26
0.59
2.9
2.9
5.8
5.9
kpa
0.06
34
264
8
53
1.52
0.58
1.1
1.1
—
—
—
0
0
23
176
1.32
0.57
1.1
1.0
—
—
—
0
0
66
573
1.18
0.56
1.4
1.4
—
—
—
0
0
24
187
1.30
0.54
4.4
3.3
2.2
2.1
mmol/l
0.02
15
137
343
3333
1.15
0.53
4.0
4.0
1.3
1.3
mmol/l
0.08
322
3072
21
161
1.32
0.53
1.8
1.7
—
—
—
0
0
27
331
0.80
0.48
1.6
1.8
—
—
—
0
0
5
81
0.61
0.46
1.2
1.4
—
—
—
0
0
5
81
0.61
0.46
1.2
1.4
—
—
—
0
0
5
81
0.61
0.46
1.2
1.4
—
—
—
0
0
68
604
1.15
0.45
1.5
1.5
—
—
—
0
0
33
275
1.22
0.45
2.9
2.9
1.6
2.1
mmol/l
0.24
28
219
17
130
1.32
0.44
1.4
1.4
—
—
—
0
0
60
531
1.15
0.42
3.1
2.4
1.2
1.1
e6/l
0.08
34
293
12
87
1.39
0.42
1.3
1.3
—
—
—
0
0
0
16
0.00
0.41
0.0
1.5
—
8.6
—
0
16
17
133
1.29
0.39
1.2
2.1
—
—
—
0
0
0
19
0.00
0.39
0.0
2.3
—
54.3
—
0
14
11
80
1.39
0.39
2.0
3.6
—
—
—
0
0
9
67
1.35
0.38
1.1
1.3
—
—
—
0
0
9
68
1.33
0.38
3.1
1.8
0.7
0.8
nmol/l
—
9
56
28
238
1.19
0.33
1.5
1.3
—
44.2
—
0
16
6
89
0.67
0.33
1.2
1.5
—
—
—
0
0
30
259
1.17
0.31
1.1
1.3
33.1
115.1
iu/ml
—
9
109
20
166
1.21
0.30
4.1
2.5
0.1
0.2
e6/l
0.45
20
159
30
260
1.17
0.29
2.9
3.4
212.6
201.6
ng/l
0.08
30
240
143
1361
1.08
0.28
2.1
1.9
98.5
95.6
pmol/l
0.26
77
683
23
196
1.18
0.27
1.2
1.3
—
—
—
0
0
39
348
1.13
0.27
1.9
1.9
—
—
—
0
0
12
95
1.27
0.26
1.4
1.7
—
—
—
0
0
10
77
1.31
0.26
1.9
2.0
—
—
—
0
0
6
83
0.72
0.24
1.2
1.2
—
1.2
—
0
8
37
411
0.89
0.24
1.7
1.7
1.4
1.5
%
0.27
31
366
13
106
1.23
0.23
1.0
1.1
—
—
—
0
0
13
107
1.22
0.22
1.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
15
126
1.20
0.21
1.7
1.7
—
172.7
—
0
11
0
12
0.00
0.21
0.0
1.1
—
4.0
—
0
12
33
297
1.12
0.21
2.8
2.0
31.4
34.3
u/l
0.32
28
251
14
166
0.84
0.21
1.9
1.7
—
—
—
0
0
6
48
1.25
0.20
4.2
4.0
327.8
365.1
umol/l
—
6
41
6
48
1.25
0.20
1.8
1.3
—
—
—
0
0
6
48
1.25
0.20
1.8
1.3
—
—
—
0
0
6
50
1.20
0.20
2.5
1.4
—
—
—
0
0
6
53
1.13
0.18
1.5
1.1
—
—
—
0
0
39
422
0.92
0.17
4.8
6.6
—
—
—
0
0
42
389
1.09
0.17
2.0
2.1
—
—
—
0
0
9
80
1.13
0.15
1.2
1.2
—
—
—
0
0
18
201
0.89
0.13
1.8
1.8
—
—
—
0
0
14
124
1.13
0.11
1.6
1.5
—
—
—
0
0
75
779
0.95
0.11
4.5
3.7
1.0
1.0
kg/l
0.68
11
94
16
145
1.11
0.09
1.3
1.5
—
—
—
0
0
5
48
1.04
0.09
1.2
1.5
—
—
—
0
0
10
88
1.14
0.08
1.3
1.3
—
30.6
—
0
10
10
111
0.90
0.06
2.2
1.7
—
—
—
0
0
11
121
0.91
0.06
2.3
1.8
—
—
—
0
0
63
613
1.03
0.06
2.1
1.7
1307.4
1190.0
nmol/l
0.27
41
466
319
3171
1.02
0.05
15.6
12.1
40.5
40.3
%
0.19
235
2327
12
111
1.08
0.04
1.3
1.3
—
1.0
—
0
7
14
149
0.94
0.03
1.3
2.0
1.5
2.7
mg/l
—
7
109
226
2270
0.99
0.01
2.9
2.9
45.0
44.7
u/l
0.02
209
2130
25
243
1.03
0.01
3.3
3.5
88.0
78.8
ng/l
0.31
18
214
11
108
1.02
0.00
1.3
1.2
—
7.7
—
0
20
42
425
0.99
0.00
5.2
4.7
32.3
32.0
%
0.08
27
280
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
102.6
—
0
5
6
63
0.95
0.00
1.5
1.6
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
102.2
—
0
5
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
2.3
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.6
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_CONNSOFT_NOS_EXALLC – Benign neoplasm: Connective and other soft tissue, unspecified
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).